SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.

Connors, Mark; Graham, Barney S; Lane, H Clifford; Fauci, Anthony S

Connors, Mark; Graham, Barney S; Lane, H Clifford; Fauci, Anthony S.

Connors M; the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C., H.C.L., A.S.F.).
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (B.S.G.).
Lane HC; the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C., H.C.L., A.S.F.).
Fauci AS; the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C., H.C.L., A.S.F.).

Ann Intern Med ; 174(5): 687-690, 2021 05.

Article in English | MEDLINE | ID: covidwho-1395257

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/prevention & control; Pneumonia, Viral/prevention & control; Vaccines, Synthetic/immunology; COVID-19/immunology; Clinical Trials as Topic; Humans; Immunogenicity, Vaccine; Pandemics/prevention & control; Patient Safety; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; SARS-CoV-2/immunology; United States; United States Food and Drug Administration; Viral Vaccines/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Vaccines, Synthetic / COVID-19 Vaccines / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google